Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool
| dc.contributor.author | Wu, Hangjian | |
| dc.contributor.author | Gazzard, Gus | |
| dc.contributor.author | King, Anthony | |
| dc.contributor.author | Morgan, James | |
| dc.contributor.author | Wright, David | |
| dc.contributor.author | Crabb, David P. | |
| dc.contributor.author | Takwoingi, Yemisi | |
| dc.contributor.author | Azuara-Blanco, Augusto | |
| dc.contributor.author | Watson, Verity | |
| dc.contributor.author | Hernández, Rodolfo | |
| dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
| dc.date.accessioned | 2024-10-17T11:29:00Z | |
| dc.date.available | 2024-10-17T11:29:00Z | |
| dc.date.issued | 2024-08-28 | |
| dc.description | We are thankful to Christopher Cardwell who provided extensive statistical assistance. We are grateful for the ongoing support of the project management group and patient representatives. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 799481 | |
| dc.identifier | 297592438 | |
| dc.identifier | 643611f3-093d-4f15-bf5e-4dd231d2b60f | |
| dc.identifier | 85203113266 | |
| dc.identifier | 39209325 | |
| dc.identifier.citation | Wu, H, Gazzard, G, King, A, Morgan, J, Wright, D, Crabb, D P, Takwoingi, Y, Azuara-Blanco, A, Watson, V & Hernández, R 2024, 'Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool', BMJ open ophthalmology, vol. 9, no. 1, e001741. https://doi.org/10.1136/bmjophth-2024-001741 | en |
| dc.identifier.doi | 10.1136/bmjophth-2024-001741 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 2397-3269 | |
| dc.identifier.other | ORCID: /0000-0003-2619-8230/work/170011187 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24425 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85203113266&partnerID=8YFLogxK | en |
| dc.identifier.vol | 9 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMJ open ophthalmology | en |
| dc.subject | Glaucoma | en |
| dc.subject | Ocular Hypertension | en |
| dc.subject | Quality-Adjusted Life Years | en |
| dc.subject | Antihypertensive Agents/therapeutic use | en |
| dc.subject | Risk Assessment | en |
| dc.subject | Humans | en |
| dc.subject | Middle Aged | en |
| dc.subject | Risk Factors | en |
| dc.subject | Ocular Hypertension/economics | en |
| dc.subject | Male | en |
| dc.subject | United Kingdom/epidemiology | en |
| dc.subject | Intraocular Pressure/physiology | en |
| dc.subject | Cost-Benefit Analysis | en |
| dc.subject | Health Care Costs/statistics & numerical data | en |
| dc.subject | Female | en |
| dc.subject | Aged | en |
| dc.subject | Ophthalmology | en |
| dc.title | Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Wu_etal_BMJOO_Cost-effectiveness_of_Monitoring_VOR.pdf
- Size:
- 780.74 KB
- Format:
- Adobe Portable Document Format
